TABLE 3.

The Bivariate and Multivariate Analyses of the Cox Proportional Hazards for the Deaths of 62 Patients Undergoing Cancer Treatment who had Detectable SARS-CoV-2 by RT-PCR Between March 1, 2020, and November 30, 2021, Followed up at the Pediatric Oncology Division at IMIP

	Hazard Risk (CI 95%)	P value	aHR (CI 95%)	P value
Age (years)	0.99 (0.90–1.08)	0.775	0.95 (0.86–1.06)	0.371
Nutritional status			–	–
Underweight	3.18 (1.10–9.20)	0.032	–	–
Overweight/obese	2.66 (0.8–8.93)	0.113	–	–
Solid tumor	3.62 (1.37–9.59)	0.009	3.99 (1.43–11.12)	0.008
Induction/consolidation phase of the oncological treatment	2.89 (1.03–8.10)	0.044	–	–
Palliative care	3.01 (0.67–13.50)	0.149	–	–
Dyspnea	5.00 (1.94–12.88)	0.001	–	–
Diarrhea	3.43 (1.21–9.74)	0.021	3.97 (1.23–12.73)	0.021
Lymphopenia (<300 mm/cel³)	1.92 (0.76–4.87)	0.170	–	–
Severe/critical COVID-19	6.57 (2.53–17.02)	<0.001	8.51 (2.91–24.80)	<0.001

aHR indicates adjusted hazard risk; Ci, confidence interval; COVID-19, coronavirus disease 2019.